SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GTC Biotherapeutics
An SI Board Since December 2005
Posts SubjectMarks Bans Symbol
135 7 0 GTCB
Emcee:  SI (no user) Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
60<b> GTCB Reports 2Q06 Results </b> <i>[The major news is thatDewDiligence_on_SI-8/3/2006
59EU Commission rubber stamps ATryn approval: investorshub.comDewDiligence_on_SI-8/2/2006
58<i>ReadMeFirst</i> primer updated for latest financing transaction aDewDiligence_on_SI-7/19/2006
57GTCB raises $17.5M in private placement: investorshub.comDewDiligence_on_SI-7/18/2006
56Updates on some (would-be) competitors: snipurl.com (albumin) snipurl.com (antDewDiligence_on_SI-7/6/2006
55<i>ReadMeFirst</i> primer updated again: investorshub.comDewDiligence_on_SI-6/16/2006
54GTCB files $35M shelf registration: investorshub.comDewDiligence_on_SI-6/16/2006
53Updated reference list of AT abstracts: iurl.bizDewDiligence_on_SI-6/16/2006
52<i>ReadMeFirst</i> primer updated with info re liquidity and news flDewDiligence_on_SI-6/10/2006
51Possible/Probable 2006 News Flow: investorshub.comDewDiligence_on_SI-6/9/2006
50GTCB <i>ReadMeFirst</i> primer updated again (additions re liquidityDewDiligence_on_SI-6/7/2006
49GTCB <i>ReadMeFirst</i> primer updated: investorshub.comDewDiligence_on_SI-6/4/2006
4870% lol. I have to keep reminding myself the FDA is not the EMEA and vice versakenhott-6/2/2006
47<i>I thought your 5% estimate was way on the low side</i> My wife, DewDiligence_on_SI-6/2/2006
46I thought your 5% estimate was way on the low side since there was no way of knorkrw-6/2/2006
45ATryn approved by EMEA on re-examination: investorshub.com Q&A from the EMEDewDiligence_on_SI-6/2/2006
44New abstract re AT+TPA in DIC/sepsis: urlcut.comDewDiligence_on_SI-5/20/2006
43KyberSept Abstract re Use of AT to Treat DIC/sepsis: urlcut.com KyberSept is thDewDiligence_on_SI-5/6/2006
42<i>ReadMeFirst</i> primer updated for 1Q06 results and CC: investorDewDiligence_on_SI-4/30/2006
411Q06 CC edited transcript: investorshub.comDewDiligence_on_SI-4/30/2006
401Q06 PR: DIC/sepsis is the surprise <i>acquired</i>-deficiency selecDewDiligence_on_SI-4/28/2006
39Biolex reports phase-1 results: investorshub.comDewDiligence_on_SI-4/27/2006
38Annual-meeting proxy has been filed: sec.govDewDiligence_on_SI-4/24/2006
37<i>ReadMeFirst</i> primer updated for miscellaneous changes: investDewDiligence_on_SI-4/21/2006
36Merrimack Pharmaceuticals Completes Enrollment for Phase 2 Trial of MM-093 In PaDewDiligence_on_SI-4/19/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News